(S)-(+)-4-Phenyl-2-Oxazolidinone CAS 99395-88-7 Puritas ≥99.0% (HPLC) Puritas Chiral ≥99.0% (GC) Compositiones Chiralis

Description:

Nomen chemicum: (S)-(+)-4-Phenyl-2-Oxazolidinone

CAS: 99395-88-7

Aspectus: Alba vel Off-alba Crystallina pulveris

Puritas: ≥99.0% (HPLC)

Puritas Chiral: ≥99.0% (GC)

Intermedia Ezetimibe (CAS: 163222-33-1) in tractatione Hypercholesterolemia

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Manufacturer Supple cum High puritate et stabulo Quality
(S)-(+)-4-Phenyl-2-Oxazolidinone CAS: 99395-88-7
(R)-(-)-4-Phenyl-2-Oxazolidinone CAS: 90319-52-1
Chiral Compounds, High Quality, Commercial Production

Chemical Properties:

Nomen chemicum (S)-(+)-4-Phenyl-2-Oxazolidinone
Synonyma (S) -4-Phenyloxazolidin-2-one
CAS Number 99395-88-7
CATTUS Number RF-PI144
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C9H9NO2
M. Pondus 163.17
Liquescens punctum 129.0~132.0℃
Ferveret 407℃ ad 760 mmHg
Density 1.195 g/cm3
Solubilitas Solutum in Chloroform, Methanol
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba vel Off-alba Crystallina pulveris
Lepidium sativum IR, HPLC
Puritas / Analysis Methodus ≥99.0% (HPLC)
Humor (KF) ≤0.50%
Individual Impurity ≤0.50%
Totalis immunditias ≤1.0%
Chiral Puritas ≥99.5% (GC)
Metalla gravis ≤10ppm
Test Standard Enterprise Standard
Consuetudinem Ezetimibe (CAS: 163222-33-1);Chiral Composita

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

1

FAQ:

2

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est praecipuum fabricam et supplementum (S)-(+)-4-Phenyl-2-Oxazolidinonis (CAS: 99395-88-7) cum magna qualitate, in synthesi adhiberi potest. de Ezetimibe (CAS: 163222-33-1).Ezetimibe est medicamentum ananti-hyperlipidemicum adhibitum ad gradus cholesteroli levandos.

Epistulam tuam hic scribe et mitte nobis